0,924  0,004  Antipsychotic
0,887  0,004  Cognition disorders treatment
0,866  0,004  Cardiovascular analeptic
0,849  0,005  Mood disorders treatment
0,841  0,005  Antidepressant
0,794  0,006  Analgesic
0,770  0,007  Analgesic, non-opioid
0,761  0,007  Antiobesity
0,741  0,004  Cholinergic
0,721  0,004  Sleep disorders treatment
0,704  0,004  Attention deficit/hyperactivity disorder treatment
0,690  0,005  HERG channel blocker
0,672  0,005  Dependence treatment
0,657  0,008  Nootropic
0,654  0,011  Anxiolytic
0,649  0,016  Alzheimer's disease treatment
0,628  0,006  Cardiodepressant
0,613  0,003  Acetylcholine nicotinic antagonist
0,612  0,007  Potassium channel (Voltage-sensitive) blocker
0,607  0,003  Acetylcholine agonist
0,616  0,012  CYP2D6 substrate
0,606  0,017  Antiparkinsonian
0,587  0,004  Insulin secretagoues
0,594  0,018  Respiratory analeptic
0,574  0,004  Cholinergic antagonist
0,573  0,004  Acetylcholine antagonist
0,573  0,006  Potassium channel blocker
0,556  0,003  Neuronal nicotinic receptor antagonist
0,544  0,006  Sigma receptor agonist
0,538  0,005  Skeletal muscle relaxant
0,533  0,006  Muscle relaxant
0,531  0,023  5 Hydroxytryptamine release stimulant
0,512  0,004  Antiemetic
0,521  0,020  Analeptic
0,490  0,005  Calcium channel activator
0,481  0,003  Acetylcholine nicotinic agonist
0,480  0,002  Acetylcholine muscarinic agonist
0,489  0,012  Psychostimulant
0,472  0,002  Acetylcholine M2 receptor agonist
0,461  0,004  Antismoking
0,455  0,005  Antialcoholic
0,450  0,002  Acetylcholine M1 receptor agonist
0,454  0,008  Antiparkinsonian, rigidity relieving
0,444  0,008  Antimigraine
0,435  0,007  Antiadrenergic
0,425  0,005  Acetylcholine M1 receptor antagonist
0,420  0,005  Acetylcholine muscarinic antagonist
0,423  0,008  Alpha-N-acetylglucosaminidase inhibitor
0,414  0,003  Nicotinic receptor alpha7 subunit antagonist
0,462  0,054  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,410  0,008  Adrenaline antagonist
0,400  0,003  Nicotinic receptor alpha3 subunit antagonist
0,412  0,015  Antiarrhythmic
0,418  0,023  Huntington's disease treatment
0,396  0,003  Dopamine D5 antagonist
0,391  0,003  Nicotinic neuronal receptor agonist
0,401  0,014  5 Hydroxytryptamine uptake stimulant
0,385  0,004  Acetylcholine M4 receptor antagonist
0,420  0,039  Immunomodulator
0,397  0,017  Anesthetic general
0,431  0,055  Antipruritic, allergic
0,373  0,003  Nicotinic alpha4beta2 receptor antagonist
0,399  0,029  Cardiotonic
0,403  0,038  Radioprotector
0,371  0,007  Cocaine dependence treatment
0,406  0,053  Vasodilator, peripheral
0,361  0,009  Antiparkinsonian, tremor relieving
0,383  0,039  CYP2D6 inhibitor
0,350  0,008  Antihistaminic
0,348  0,008  Histamine antagonist
0,343  0,005  Opioid kappa receptor antagonist
0,340  0,006  Alpha 2 adrenoreceptor antagonist
0,334  0,003  Nicotinic receptor alpha4 subunit antagonist
0,343  0,012  NOS3 expression enhancer
0,372  0,046  Spasmolytic
0,356  0,032  Antineoplastic (liver cancer)
0,349  0,025  Sedative
0,337  0,013  5 Hydroxytryptamine 1E antagonist
0,330  0,007  5 Hydroxytryptamine agonist
0,358  0,042  Antidiabetic (type 2)
0,346  0,033  Flavin-containing monooxygenase substrate
0,315  0,004  Acetylcholine M2 receptor antagonist
0,329  0,018  Diuretic
0,340  0,032  DNA synthesis inhibitor
0,311  0,004  Antiviral (Ebola)
0,307  0,002  Acetylcholine M4 receptor agonist
0,312  0,015  Alpha adrenoreceptor antagonist
0,320  0,023  Urinary incontinence treatment
0,302  0,007  Uterine stimulant
0,313  0,019  Antiviral (Hepatitis)
0,295  0,002  Acetylcholine M3 receptor agonist
0,299  0,007  Alpha 2a adrenoreceptor antagonist
0,366  0,075  Ulceration
0,292  0,004  5 Hydroxytryptamine 3 antagonist
0,292  0,006  5 Hydroxytryptamine uptake inhibitor
0,331  0,046  FMO3 substrate
0,285  0,004  Acetylcholine M5 receptor antagonist
0,284  0,003  Antineoplastic alkaloid
0,279  0,004  5 Hydroxytryptamine 3A agonist
0,324  0,051  Antineurogenic pain
0,300  0,030  Antihypotensive
0,275  0,004  Dopamine uptake inhibitor
0,285  0,016  Antiviral (Hepatitis C)
0,272  0,004  Acetylcholine M3 receptor antagonist
0,277  0,018  Antipruritic
0,258  0,007  Sigma receptor antagonist
0,266  0,022  Antiviral (Influenza A)
0,246  0,004  Acetylcholine release stimulant
0,336  0,094  Immunosuppressant
0,289  0,053  Antiglaucomic
0,262  0,027  Irritable Bowel syndrome treatment
0,282  0,046  Gastrin inhibitor
0,239  0,004  Prokinetic
0,246  0,012  Chemokine receptor antagonist
0,290  0,057  Tumour necrosis factor alpha release inhibitor
0,288  0,055  Superoxide dismutase inhibitor
0,237  0,005  Adrenaline uptake inhibitor
0,240  0,009  Opioid antagonist
0,235  0,005  Prolactin inhibitor
0,263  0,034  Pneumotoxic
0,242  0,017  Toll-Like receptor antagonist
0,232  0,009  CC chemokine receptor antagonist
0,226  0,004  Nociceptin (N/OFQ) receptor antagonist
0,225  0,003  Tourette's syndrome treatment
0,279  0,059  Vascular (periferal) disease treatment
0,271  0,051  Tyrosine 3 hydroxylase inhibitor
0,289  0,071  CYP2C19 substrate
0,239  0,021  5 Hydroxytryptamine 3E antagonist
0,230  0,013  Alpha 2c adrenoreceptor antagonist
0,281  0,064  Amyotrophic lateral sclerosis treatment
0,222  0,004  Peristaltic stimulant
0,277  0,061  Urologic disorders treatment
0,264  0,049  Ca2+/calmodulin-dependent kinase IV inhibitor
0,279  0,065  GST M1-1 substrate
0,217  0,003  Acetylcholine M5 receptor agonist
0,218  0,004  Neurokinin 1 antagonist
0,215  0,003  Nicotinic alpha3beta2 receptor antagonist
0,229  0,017  Alpha 1 adrenoreceptor antagonist
0,227  0,018  Alpha 2b adrenoreceptor antagonist
0,352  0,144  Caspase 9 stimulant
0,211  0,004  Neurokinin antagonist
0,222  0,015  Raynaud's phenomenon treatment
0,218  0,014  Alpha 1a adrenoreceptor antagonist
0,286  0,084  Interleukin 2 agonist
0,205  0,004  Dopamine transporter inhibitor
0,297  0,096  Transcription factor NF kappa B inhibitor
0,221  0,020  Antitussive
0,248  0,048  Abortion inducer
0,202  0,004  Dipeptidyl peptidase inhibitor
0,225  0,029  5 Hydroxytryptamine antagonist
0,200  0,004  Potassium channel (Inward rectifier) blocker
0,213  0,018  GABA C receptor agonist
0,315  0,124  Antibacterial
0,200  0,010  Dopamine D1 antagonist
0,210  0,022  Autism spectrum disorders treatment
0,222  0,035  Prostate disorders treatment
0,238  0,052  Antiviral (Influenza)
0,195  0,009  Opioid mu receptor antagonist
0,185  0,001  Nicotinic alpha3beta4 receptor agonist
0,187  0,006  Antiprotozoal activity enhancer
0,295  0,113  GST A substrate
0,281  0,100  FMO1 substrate
0,217  0,037  Antiischemic, cerebral
0,272  0,093  Antimycobacterial
0,277  0,100  Antihypertensive
0,320  0,144  5 Hydroxytryptamine release inhibitor
0,205  0,030  Bipolar disorder treatment
0,180  0,005  Histamine H3 receptor antagonist
0,177  0,003  Nociceptin (N/OFQ) receptor agonist
0,176  0,005  Opioid kappa receptor agonist
0,257  0,090  Insulysin inhibitor
0,248  0,080  Interleukin agonist
0,171  0,003  Dipeptidyl peptidase IV inhibitor
0,194  0,027  Nav1.3 sodium channel blocker
0,262  0,096  Metabolic disease treatment
0,189  0,023  Nav1.6 sodium channel blocker
0,170  0,004  5 Hydroxytryptamine 3 agonist
0,167  0,002  Nicotinic alpha4 receptor agonist
0,277  0,113  CYP3A4 substrate
0,188  0,025  Movement disorders treatment
0,312  0,152  Antidiabetic
0,312  0,152  Cyclophilin D inhibitor
0,161  0,002  Nicotinic alpha4beta2 receptor agonist
0,163  0,005  Narcotic antagonist
0,182  0,024  Hearing loss treatment
0,270  0,114  Antineoplastic (lung cancer)
0,169  0,013  Alpha adrenoreceptor agonist
0,160  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,194  0,042  UGT2B9 substrate
0,156  0,004  Nicotinic alpha7 receptor agonist
0,157  0,006  Glycine receptor agonist
0,210  0,060  CYP2B6 inhibitor
0,172  0,022  Dopamine antagonist
0,158  0,008  Narcolepsy treatment
0,203  0,058  Diabetic retinopathy treatment
0,152  0,007  Glycine receptor antagonist
0,152  0,007  Opioid agonist
0,159  0,016  Electrolyte absorption antagonist
0,192  0,049  Toxic, respiratory center
0,197  0,056  Prostatic (benign) hyperplasia treatment
0,162  0,021  Ca2+-transporting ATPase inhibitor
0,194  0,053  Eye irritation, high
0,262  0,122  Vasodilator, coronary
0,144  0,005  5 Hydroxytryptamine 2C agonist
0,241  0,104  Antiepileptic
0,151  0,015  Analgesic, opioid
0,170  0,033  5 Hydroxytryptamine 2B antagonist
0,141  0,007  Sodium/hydrogen exchanger 5 inhibitor
0,139  0,006  5 Hydroxytryptamine 3A antagonist
0,170  0,037  Antiviral (Hepatitis B)
0,137  0,005  Cyclin-dependent kinase 6 inhibitor
0,149  0,017  NMDA 2 receptor antagonist
0,194  0,062  Diabetic nephropathy treatment
0,153  0,021  Posttraumatic stress disorder treatment
0,181  0,049  Neurotensin receptor agonist
0,139  0,007  Alpha 2 adrenoreceptor agonist
0,182  0,052  Hair growth stimulant
0,148  0,018  GST T1-1 substrate
0,144  0,014  Tocolytic
0,150  0,021  Toll-Like receptor 4 antagonist
0,133  0,005  Orexin receptor antagonist
0,150  0,023  Dopamine D2 antagonist
0,135  0,008  Toll-Like receptor 7 antagonist
0,237  0,110  Antihypoxic
0,138  0,011  mTOR complex 2 inhibitor
0,194  0,068  Sepsis treatment
0,165  0,040  Adenylate cyclase stimulant
0,174  0,050  Anesthetic
0,131  0,007  5 Hydroxytryptamine 2A agonist
0,128  0,006  Antimycoplasmal
0,138  0,017  Mental retardation treatment
0,171  0,050  Toll-Like receptor 9 antagonist
0,228  0,108  Radiosensitizer
0,160  0,041  5 Hydroxytryptamine 2 antagonist
0,168  0,049  SULT1A3 substrate
0,123  0,005  Orexin receptor 1 antagonist
0,194  0,076  UGT1A1 substrate
0,259  0,142  CYP2C9 substrate
0,182  0,065  Tumour necrosis factor antagonist
0,181  0,065  Antirickettsial
0,124  0,008  Uterine relaxant
0,189  0,074  VEGF expression inhibitor
0,123  0,008  Glycine transporter inhibitor
0,260  0,145  Antineoplastic (non-Hodgkin's lymphoma)
0,134  0,020  Antidote, mercury
0,130  0,016  Histamine H2 receptor antagonist
0,174  0,061  Arachidonic acid antagonist
0,150  0,037  Gastritis treatment
0,192  0,080  Osteoarthritis treatment
0,162  0,050  Nav1.2 sodium channel blocker
0,221  0,111  Chemoprotective
0,143  0,033  Antineoplastic, alkylator
0,129  0,019  Restless leg syndrome treatment
0,113  0,005  Nicotinic receptor beta4 subunit antagonist
0,160  0,052  Antifungal enhancer
0,220  0,112  Antituberculosic
0,129  0,021  5 Hydroxytryptamine 1F antagonist
0,118  0,011  Sleep apnea treatment
0,262  0,156  TNF expression inhibitor
0,109  0,004  5 Hydroxytryptamine 2B agonist
0,108  0,005  Glycine transporter 1 inhibitor
0,110  0,008  Histamine agonist
0,107  0,005  Histamine H4 receptor antagonist
0,104  0,004  Dipeptidyl peptidase I inhibitor
0,109  0,009  Antidote, organophosphates
0,170  0,073  Phospholipase C inhibitor
0,106  0,008  5 Hydroxytryptamine 2 agonist
0,106  0,009  MAP kinase kinase 7 inhibitor
0,110  0,013  CC chemokine 5 receptor agonist
0,244  0,148  Stroke treatment
0,103  0,008  Glutamate (mGluR group I) agonist
0,123  0,031  Histamine H1 receptor antagonist
0,144  0,052  Anesthetic local
0,113  0,022  Dopamine D3 antagonist
0,099  0,007  Glutamate (mGluR5) agonist
0,167  0,076  ATPase inhibitor
0,103  0,013  CC chemokine 2 receptor antagonist
0,136  0,046  Microtubule formation inhibitor
0,160  0,070  Neuropathy treatment
0,104  0,016  Alpha 1 adrenoreceptor agonist
0,157  0,069  Interferon gamma antagonist
0,246  0,158  GABA C receptor rho-3 antagonist
0,230  0,143  Antithrombotic
0,190  0,103  Antineoplastic (lymphoma)
0,131  0,045  Choleretic
0,125  0,040  Chronic obstructive bronchitis treatment
0,091  0,006  Substance P antagonist
0,112  0,027  Antileprosy
0,162  0,079  UGT2B10 substrate
0,093  0,010  Antihemophilic
0,168  0,087  LDLR expression enhancer
0,145  0,063  Calcium channel blocker
0,089  0,008  Alpha-mannosidase inhibitor
0,118  0,038  5 Hydroxytryptamine 2A antagonist
0,085  0,005  Orexin receptor 2 antagonist
0,121  0,042  Obsessive-compulsive disorder treatment
0,084  0,006  5 Hydroxytryptamine 3B antagonist
0,146  0,068  Sphingosine 1-phosphate receptor 5 antagonist
0,114  0,036  Triose-phosphate isomerase inhibitor
0,154  0,077  Carcinogenic, group 1
0,128  0,052  Antiviral (Influenza B)
0,187  0,111  Platelet antagonist
0,158  0,082  UGT2B7 substrate
0,078  0,003  Guanylate cyclase inhibitor
0,180  0,105  Teratogen
0,081  0,006  Dopamine D5 agonist
0,087  0,012  Sphingosine kinase 2 inhibitor
0,136  0,062  Antihelmintic (Trematoda)
0,125  0,051  Excitatory amino acid transporter EAAC1 inhibitor
0,084  0,011  5 Hydroxytryptamine 4 antagonist
0,083  0,009  Anesthetic inhalation
0,144  0,072  Cell wall synthesis inhibitor
0,144  0,074  Neuropeptide Y1 antagonist
0,084  0,014  Phosphodiesterase 1A inhibitor
0,166  0,095  Systemic lupus erythematosus treatment
0,188  0,119  Myocardial infarction treatment
0,091  0,021  Phospholipase D inhibitor
0,082  0,013  CC chemokine 5 receptor antagonist
0,079  0,011  Prolyl endopeptidase inhibitor
0,107  0,039  Antithrombocytopenic
0,118  0,052  Antiviral (Poxvirus)
0,269  0,203  Autoimmune disorders treatment
0,087  0,021  Gaucher disease treatment
0,087  0,021  Androgen agonist
0,101  0,035  Alpha 1b adrenoreceptor antagonist
0,067  0,003  Vesicular acetylcholine transporter inhibitor
0,129  0,065  Cathepsin H inhibitor
0,202  0,138  UGT2B4 substrate
0,069  0,006  Vascular adhesion protein 1 inhibitor
0,133  0,070  Sodium channel (voltage-gated) blocker
0,194  0,131  Neuropeptide Y2 antagonist
0,076  0,014  Prolactin release inhibitor
0,135  0,074  Neurotrophic factor
0,073  0,012  Neurokinin 3 antagonist
0,085  0,024  Potassium channel (Tandem pore domain) blocker
0,169  0,108  Anticonvulsant
0,109  0,051  Anabolic
0,067  0,009  Antihyperaldosteronism
0,083  0,026  Protein kinase C beta inhibitor
0,108  0,051  Creatine kinase inhibitor
0,071  0,014  Aldosterone antagonist
0,115  0,058  GABA C receptor antagonist
0,068  0,012  Mannosidase inhibitor
0,084  0,028  Anticholelithogenic
0,089  0,033  Opioid delta receptor antagonist
0,070  0,015  Smo receptor antagonist
0,066  0,012  CC chemokine 4 receptor antagonist
0,136  0,082  Pregnane X receptor agonist
0,178  0,124  Cytostatic
0,247  0,194  MAP kinase kinase 6 inhibitor
0,070  0,016  Neurokinin 2 antagonist
0,093  0,040  5 Hydroxytryptamine 1 antagonist
0,098  0,044  Gastroesophageal reflux disease treatment
0,227  0,174  Histamine release inhibitor
0,163  0,110  Embryotoxic
0,069  0,017  CC chemokine 3 receptor antagonist
0,087  0,035  Cushing's syndrome treatment
0,058  0,007  Dipeptidyl peptidase II inhibitor
0,150  0,100  Aldehyde oxidase substrate
0,072  0,023  Sphingosine kinase inhibitor
0,103  0,054  Glutamate (mGluR7) agonist
0,053  0,004  Potassium channel (Inward rectifier) 1 blocker
0,073  0,025  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,113  0,066  Calcium channel (voltage-sensitive) blocker
0,091  0,044  Glutamate receptor agonist
0,050  0,004  5 Hydroxytryptamine 4 agonist
0,057  0,011  DNA gyrase subunit A inhibitor
0,095  0,049  5 Hydroxytryptamine 2C antagonist
0,063  0,017  Secretase gamma inhibitor
0,061  0,015  5-Alpha-reductase inhibitor
0,079  0,035  Cyclin-dependent kinase 4 inhibitor
0,163  0,120  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,204  0,161  Cholesterol antagonist
0,095  0,052  Actinic keratosis treatment
0,093  0,051  NMDA receptor antagonist
0,068  0,026  Bombesin 3 receptor antagonist
0,046  0,006  Adenosine uptake inhibitor
0,075  0,034  SULT2A1 substrate
0,044  0,003  NMDA receptor phencyclidine site antagonist
0,066  0,026  NMDA 2A receptor antagonist
0,099  0,059  UGT2B11 substrate
0,047  0,007  Tryptophan 5 hydroxylase inhibitor
0,060  0,021  HCV NS3/NS4A protease inhibitor
0,081  0,041  Aminopeptidase I inhibitor
0,073  0,034  Glutamate (mGluR6) antagonist
0,080  0,041  Vanilloid 4 agonist
0,052  0,014  Arginase inhibitor
0,050  0,013  Vesicle monoamine transporter inhibitor
0,041  0,004  Antibiotic Quinolone-like
0,071  0,035  DNA gyrase inhibitor
0,045  0,009  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,042  0,006  5 Hydroxytryptamine 1F agonist
0,072  0,037  Potassium channel (ATP-sensitive) blocker
0,070  0,035  Carbamoyl phosphate synthetase inhibitor
0,081  0,047  Viral attachment inhibitor
0,040  0,005  Antibiotic Naphthyridine-like
0,087  0,053  Antispirochetal
0,114  0,081  Contraceptive female
0,062  0,029  Glucosylceramidase inhibitor
0,061  0,029  Pregnane X receptor antagonist
0,049  0,017  Alpha 1d adrenoreceptor agonist
0,110  0,078  Calcium channel N-type blocker
0,075  0,043  5 Hydroxytryptamine 1A antagonist
0,107  0,076  TRPA1 agonist
0,067  0,036  NMDA 2C receptor antagonist
0,037  0,007  HCV NS5A inhibitor
0,061  0,030  Toll-Like receptor 8 antagonist
0,062  0,032  5 Hydroxytryptamine 1 agonist
0,075  0,045  Calcium channel L-type blocker
0,200  0,171  CYP3A4 inhibitor
0,063  0,034  CDK4/cyclin D inhibitor
0,089  0,060  Phosphodiesterase I inhibitor
0,067  0,038  Dopamine D4 antagonist
0,062  0,034  Cyclin A1 inhibitor
0,183  0,156  Antiviral (West Nile virus)
0,037  0,010  DNA topoisomerase IV inhibitor
0,120  0,093  Antianorexic
0,059  0,032  NMDA 2B receptor antagonist
0,053  0,026  CC chemokine receptor 2B antagonist
0,058  0,031  Lysine-specific demethylase 1A inhibitor
0,101  0,074  Antihypermotility
0,040  0,014  CDK6/cyclin D3 inhibitor
0,087  0,061  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,038  0,013  Sigma 2 receptor antagonist
0,074  0,049  Cathepsin G inhibitor
0,096  0,071  Nav1.1 sodium channel blocker
0,053  0,029  Glycine transporter 2 inhibitor
0,033  0,008  5-Alpha-reductase 1 inhibitor
0,107  0,082  Antiprotozoal (Babesia)
0,054  0,031  Phosphodiesterase 7A inhibitor
0,127  0,104  Anticoagulant
0,085  0,061  Histamine N-methyltransferase inhibitor
0,166  0,142  Immunostimulant
0,051  0,028  Opioid mu receptor agonist
0,032  0,009  5-Alpha-reductase 2 inhibitor
0,045  0,022  Sphingosine kinase 1 inhibitor
0,134  0,111  Antipruritic, non-allergic
0,044  0,022  Kainate receptor agonist
0,074  0,052  Antibiotic
0,132  0,110  Heat shock protein 70 antagonist
0,062  0,041  Cannabinoid CB1 receptor agonist
0,104  0,083  Alkylator
0,043  0,022  GABA uptake inhibitor
0,130  0,110  Pulmonary hypertension treatment
0,144  0,124  Succinate dehydrogenase inhibitor
0,041  0,021  Antiviral (Bovine viral diarrhea virus)
0,092  0,073  Bronchodilator
0,104  0,086  Menstruation disorders treatment
0,074  0,056  Na+ K+ transporting ATPase inhibitor
0,047  0,029  Premature ejaculation treatment
0,203  0,185  Ca(v)3.3 blocker
0,064  0,046  Cannabinoid receptor agonist
0,099  0,081  SULT1A1 substrate
0,210  0,192  Antiasthmatic
0,032  0,015  Melatonin antagonist
0,031  0,014  Baculoviral IAP repeat-containing protein 4 inhibitor
0,021  0,004  Cyclin D2 inhibitor
0,040  0,023  Farnesoid X receptor agonist
0,093  0,077  Expectorant
0,115  0,099  Protein kinase stimulant
0,179  0,163  UGT1A9 substrate
0,044  0,028  Oxytocin agonist
0,031  0,016  Purinergic P2Y15 antagonist
0,020  0,005  CC chemokine 10 receptor antagonist
0,033  0,018  Epoxide hydrolase 1 inhibitor
0,026  0,011  Glutamate (mGluR1a) agonist
0,089  0,074  UDP-glucose 4-epimerase inhibitor
0,057  0,042  CDK4/cyclin D1 inhibitor
0,048  0,033  Cholesterol esterase inhibitor
0,034  0,020  Carboxypeptidase B inhibitor
0,046  0,032  5 Hydroxytryptamine 1A agonist
0,100  0,085  Nav1.5 sodium channel blocker
0,185  0,171  NOS3 expression inhibitor
0,036  0,023  Ceramide glucosyltransferase inhibitor
0,048  0,035  Cytokine production stimulant
0,058  0,045  Potassium channel intermediate-conductance Ca-activated blocker
0,035  0,023  Glucose-dependent insulinotropic receptor agonist
0,070  0,057  Glutamate dehydrogenase inhibitor
0,110  0,098  Sodium channel blocker
0,039  0,027  MAP3K5 inhibitor
0,026  0,014  Glutamate (mGluR1) agonist
0,059  0,048  Corticotropin releasing factor 2 receptor antagonist
0,065  0,053  Glutamate (mGluR7) antagonist
0,018  0,007  Sodium/hydrogen exchanger 3 inhibitor
0,050  0,040  Melanin-concentrating hormone receptor 1 antagonist
0,047  0,037  Dopamine beta hydroxylase inhibitor
0,042  0,032  Glutamate (mGluR4) antagonist
0,150  0,139  Aldehyde oxidase inhibitor
0,123  0,113  Cyclin-dependent kinase 8 inhibitor
0,043  0,033  Potassium channel small-conductance Ca-activated blocker
0,076  0,066  AXL receptor tyrosine kinase inhibitor
0,090  0,081  Falcipain 3 inhibitor
0,106  0,097  Antiprotozoal (Amoeba)
0,152  0,143  MAP kinase kinase 5 inhibitor
0,053  0,044  5 Hydroxytryptamine 6 antagonist
0,019  0,010  CXC chemokine 5 receptor antagonist
0,050  0,042  Alpha 1L adrenoreceptor antagonist
0,042  0,033  Heme oxygenase inhibitor
0,061  0,053  Calcium channel P-type blocker
0,042  0,034  Purinergic P2Y antagonist
0,037  0,029  Cyclin D3 inhibitor
0,053  0,045  Glutamate (mGluR1) antagonist
0,045  0,038  Antiviral (Enterovirus)
0,045  0,037  Baculoviral IAP repeat-containing protein inhibitor
0,091  0,084  Adenylate kinase inhibitor
0,027  0,020  Hedgehog signaling activator
0,127  0,120  Liver fibrosis treatment
0,033  0,027  Tubulin agonist
0,024  0,018  Calcitonin gene-related peptide antagonist
0,026  0,020  Histamine H3 receptor agonist
0,016  0,010  Thromboxane A2 agonist
0,018  0,013  Histamine H4 receptor agonist
0,058  0,053  Hyperparathyroidism treatment
0,052  0,047  Alpha 1d adrenoreceptor antagonist
0,027  0,023  5 Hydroxytryptamine 6 agonist
0,082  0,078  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,048  0,044  Cannabinoid CB2 receptor agonist
0,081  0,077  HIV-1 integrase (Overall Integration) inhibitor
0,021  0,018  GRP78 expression inhibitor
0,050  0,047  Argininosuccinate synthase inhibitor
0,095  0,092  Carcinogenic, group 3
0,112  0,109  Vanilloid 1 agonist
0,044  0,041  Glucose-6-phosphate isomerase inhibitor
0,189  0,187  Multiple sclerosis treatment
0,160  0,158  DNA damaging
0,082  0,080  Aminopeptidase B inhibitor
0,029  0,028  GABA transporter 3 inhibitor
0,010  0,009  Melatonin 5 antagonist
0,019  0,019  Baculoviral IAP repeat-containing protein 3 inhibitor
0,013  0,012  Proline transporter inhibitor

